| pubmed-article:15742435 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15742435 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15742435 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:15742435 | lifeskim:mentions | umls-concept:C0025664 | lld:lifeskim |
| pubmed-article:15742435 | lifeskim:mentions | umls-concept:C1880198 | lld:lifeskim |
| pubmed-article:15742435 | lifeskim:mentions | umls-concept:C1701901 | lld:lifeskim |
| pubmed-article:15742435 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15742435 | pubmed:dateCreated | 2005-3-2 | lld:pubmed |
| pubmed-article:15742435 | pubmed:abstractText | A willingness-to-pay (WTP) survey measures the value of a given intervention in money terms. We examined the WTP of Canadian patients with rheumatoid arthritis (RA) for a hypothetical cure for RA under private and public scenarios. The validity of the survey was explored by studying the association between WTP and variables thought to be associated with WTP and randomly-varied variables of the survey materials. | lld:pubmed |
| pubmed-article:15742435 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15742435 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15742435 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15742435 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15742435 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15742435 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:DonaldsonCamC | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:FautrelBrunoB | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:GuilleminFran... | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:FortinPaul... | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:St-PierreYvan... | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:ClarkeAnn EAE | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:PenrodJohn... | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:AdamVivianeV | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:PanaritisTina... | lld:pubmed |
| pubmed-article:15742435 | pubmed:author | pubmed-author:MenardHenri... | lld:pubmed |
| pubmed-article:15742435 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15742435 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:15742435 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15742435 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15742435 | pubmed:pagination | 443-53 | lld:pubmed |
| pubmed-article:15742435 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:meshHeading | pubmed-meshheading:15742435... | lld:pubmed |
| pubmed-article:15742435 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15742435 | pubmed:articleTitle | Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective. | lld:pubmed |
| pubmed-article:15742435 | pubmed:affiliation | Department of Rheumatology, Hospital Pitié-Salpêtrière, 83 bd de l'Hôpital, 75013 Paris, France. bruno.fautrel@psl.ap-hop-paris.fr | lld:pubmed |
| pubmed-article:15742435 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15742435 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
